GENERAL25 Sept 2026
Motilal Oswal believes IRDAI draft is positive for this insurance stock, sees 31% upside- Check target price, rationale | Stock Market News
IRDAI, India's insurance regulator, has proposed draft rules on how insurance is distributed. Niva Bupa says this helps over the medium term, though growth may slip briefly. Motilal Oswal keeps its Buy rating with a ₹100 target, a 31% upside. The stock closed 1.63% higher at ₹77.38. Lower commissions may keep prices flat for longer. Watch how these rules affect your policy.
Key Statutory Highlights
- IRDAI proposed sweeping distribution regulation reforms for the insurance industry.
- Niva Bupa said the draft norms are positive over the medium term but may have a minor impact on near-term growth.
- Motilal Oswal maintained a Buy rating on Niva Bupa with a target price of ₹100 per share, seeing a 31% upside.
Actionable Advice for Taxpayers / Founders:If you hold or plan to buy this stock, treat the broker's target as an opinion, not a promise, and wait to see the final IRDAI rules before deciding. If you are a policyholder, keep an eye on whether commission changes affect your premiums.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: